arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

PULSE BIOSCIENCES, INC.

PLSE

$42.30 ▲ +4.46 (+11.79%) at close

12 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

PULSE BIOSCIENCES, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.9B

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -95.4% ↘

FCF / Share $-0.81 ↘

Trailing P/E —

Price / Book 35.6x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

12-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$350.00K

— —

Net Income Profit after all expenses

$-72.78M

↓ -35.8% —

FCF / Share Free cash flow per share

$-0.81

↓ -29.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Revenue Growth YoY (%)	—	—	N/M	-50.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-733%)	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-17.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-8.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	50.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	24.6% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-35.8% Weak ↓ Weak Declining Year-over-year change in net income	-26.9% Weak ↓ Weak Declining Year-over-year change in net income	27.9% Excellent ↑ Excellent Improving Year-over-year change in net income	8.1% Fair ↑ Fair Improving Year-over-year change in net income	-27.7% Weak ↓ Weak Declining Year-over-year change in net income	-6.1% Weak ↑ Weak Improving Year-over-year change in net income	-25.1% Weak ↑ Weak Improving Year-over-year change in net income	-46.8% Weak ↑ Weak Improving Year-over-year change in net income	-168.6% Weak Weak Year-over-year change in net income	-238.6% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-29.3% Weak ↓ Weak Declining Year-over-year change in free cash flow	6.3% Fair ↓ Fair Declining Year-over-year change in free cash flow	52.3% Excellent Excellent Year-over-year change in free cash flow	28.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-20.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—
FCF / Net Income (x)	0.75x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Return on Invested Capital (%)	-95.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-98.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2582.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-176.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-172.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-120.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-44.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-43.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-25.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-81.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-42.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-73.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-74.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-116.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-121.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-112.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-53.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-51.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-31.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-90.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-702%)	-46.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-411%)	-95.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-734%)	—	-178.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1289%)	-217.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1552%)	-152.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1119%)	-56.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-477%)	-55.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-471%)	-37.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-351%)	-20.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-237%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Net Debt (USD)	$-80.73M	$-118.04M	$-44.37M	$-61.14M	$-28.61M	$-12.46M	$-6.90M	$-51.10M	$-3.39M	$-2.09M	$-3.61M	$-7.01M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Revenue per Share (USD)	$0.01	$0.00	$0.00	$0.02	$0.05	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.08	$-0.92	$-0.85	$-1.72	$-2.28	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.81	$-0.62	$-0.67	$-1.40	$-1.95	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.19	$1.74	$0.80	$-0.06	$1.20	$0.90	$1.48	$3.22	$2.73	$1.90	$1.81	—
Tangible Book Value per Share (USD)	$1.15	$1.70	$0.75	$-0.14	$1.11	$0.79	$1.34	$3.09	$2.57	$1.69	$1.44	—
Basic Weighted Avg Shares (shares)	67.40M	58.40M	49.74M	33.94M	27.96M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Working Capital (USD)	$75.50M	$109.39M	$38.62M	$56.17M	$28.11M	$14.75M	$21.94M	$57.25M	$36.27M	$15.65M	$3.34M	—
Total Equity (USD)	$80.66M	$114.86M	$44.36M	$-2.25M	$35.69M	$22.89M	$30.74M	$66.33M	$45.99M	$25.30M	$13.66M	$16.07M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Sales/Revenue/Turnover (USD)	$350.00K	$0.00	$0.00	$700.00K	$1.42M	—	—	—	—	—	—	—
Depreciation Expense (USD)	$406.00K	$512.00K	$542.00K	$690.00K	$480.00K	$430.00K	$494.00K	$645.00K	$336.00K	$94.00K	$51.00K	—
Net Income, GAAP (USD)	$-72.78M	$-53.59M	$-42.21M	$-58.51M	$-63.66M	$-49.85M	$-46.97M	$-37.55M	$-25.57M	$-9.52M	$-2.81M	—
Operating Cash Flow (USD)	$-54.12M	$-36.34M	$-33.04M	$-47.01M	$-54.10M	$-35.37M	$-34.19M	$-23.90M	$-11.09M	$-8.05M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 46 quarters

PULSE BIOSCIENCES, INC.

Analytical Summary

12-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare PLSE with peers